Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Outstanding (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Shares Outstanding data on record, last reported at $647500.0 in Q3 2023.

  • For Q3 2023, Shares Outstanding fell 98.58% year-over-year to $647500.0; the TTM value through Sep 2023 reached $647500.0, down 98.58%, while the annual FY2022 figure was $45.8 million, 3.4% up from the prior year.
  • Shares Outstanding reached $42.8 million in Q3 2023 per CGEM's latest filing, roughly flat from $42.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $45.8 million in Q4 2022 and bottomed at $647500.0 in Q1 2023.
  • Average Shares Outstanding over 4 years is $35.5 million, with a median of $43.5 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 117.91% in 2021, then plummeted 98.58% in 2023.
  • A 4-year view of Shares Outstanding shows it stood at $29.8 million in 2020, then soared by 48.48% to $44.3 million in 2021, then grew by 3.4% to $45.8 million in 2022, then tumbled by 98.59% to $647500.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $647500.0 in Q3 2023, $42.7 million in Q2 2023, and $647500.0 in Q1 2023.